TIME health

I Got Rid of My Breasts So I Wouldn’t End Up Like My Mom

Bra with Breast Cancer ribbon
Getty Images

Since both my parents died of cancer, I started to worry that maybe I would follow suit


This story originally appeared on xoJane.com.

I remember the first time I went bra shopping.

I was 13 and I didn’t really NEED a bra, but everyone in my class was starting to wear one and I just wanted to fit in and be cool.

It was embarrassing to drag my dad to Victoria’s Secret with me. I would have dragged my mom like all the other girls at school, but I didn’t have a mom. She had died of breast cancer a few months prior.

Growing up, I missed my mother terribly. I wasn’t capable of being a happy-go-lucky college or high school student. I’d hear other high school girls whine about having a bad hair day and all I kept thinking was, “Be thankful you even have hair! That you don’t have to go through chemo and lose it all!”

When I was 23, my father was diagnosed with terminal brain cancer. He died a year later and I never felt so alone. I had no one telling me to go get my teeth cleaned or go to the doctor for check-ups; suddenly it was all in my hands.

Since both my parents died of cancer, I started to worry that maybe I would follow suit. That’s when I paid a visit to my mom’s former oncologist. She had diagnosed my mother when I was merely a fetus. I sat down in her office and she informed me that both my mother and I tested positive for the BRCA 1 mutation, putting me at a very high risk for breast and ovarian cancer. (This is the same mutation Angelina Jolie had.)

I was a mutant. Not even a cool mutant like the ninja turtle kind or one of the X-Men superheroes. I didn’t get to eat pizza in a sewer or turn into a werewolf. I was just really good at making breast tumors. I felt like I was literally becoming my mother. I was terrified I’d end up with her fate.

I didn’t even need to think it over; I knew right then and there that I was going to get rid of my boobs.

Within a week, I had already met with multiple breast and plastic surgeons. I researched, I Googled, I joined support groups, I saw more boobs in the span of a few days than most pervy high school boys. For the few months I had left to live with my real boobs, I prepped to part with them forever. I wrote them a proper good-bye letter, had a low key “photoshoot,” and I even let some boys squeeze them a day before my surgery.

However, this wasn’t easy. I was plunging head first into very major surgery, all alone.

All of a sudden I was faced with choices I never imagined I’d have to make. Should I keep my nipples? Keeping them would raise my breast cancer slightly, but I still desperately wanted to be able to look down at my chest and feel like my old self. I had no mom to call and help me with these gut wrenching and personal decisions.

Then, of course, the question I got asked by everyone was how big I was going. Luckily, this decision came very easy to me as my main goal was just to have my boobs look like my original ones.

My mastectomy process involved two surgeries. The first one was the most difficult. All my breast tissue was removed and two tissue expanders were placed in my chest muscle. I woke up with a chest of an adolescent child. For the first few weeks, I was essentially boobless.

I was really nervous about this period but I kind of enjoyed being flat-chested. Shirts and dress fit me differently and I could wear very low cut tops without worrying my boobs would fall out.

Over the course a few months, these chest expanders were gradually filled with saline and I watch my chest grow a teeny bit every few weeks. I called it “puberty in fast-forward.”

I had my final surgery of the reconstruction process last month and my chest expanders were swapped out for silicone implants

I didn’t have a Brad Pitt or even a significant other to hold my hand and kiss my forehead telling me it’ll be OK or at least bring me pizza on demand. I didn’t have millions of dollars to pay assistants to help me through recovery. I certainly didn’t have the famous name to get me first in line with the most respected surgeons in Los Angeles. Luckily, I also didn’t have US Weekly on my back so I didn’t have to hide and I could look like crap at the hospital and no one would care.

I stayed with my very generous friends who helped and supported me immensely. It was not an easy process — it involved two surgeries, but I did it and I couldn’t be happier that it’s behind me.

The hardest part of the whole process wasn’t the surgery or the pain. It was asking for help. I wasn’t capable of lifting my arms for a few weeks; I couldn’t dress or bathe myself. Putting on makeup and even washing my face felt impossible. I also wasn’t quite sure how my insurance would cover the surgery and how I could afford it. I had to start asking for help and advice, something that has always been difficult for me. Since I was a caretaker for both my parents when they were sick, I was used to being the strong one. Now I had to find other people to be my source of strength.

Now I’m really proud of my boobs. I wish I could show my new boobs off without coming off as slutty or like an attention whore. Mainly, I want to prove to other people, “LOOK! You can get a life-saving mastectomy and your boobs can look this awesome!”

Maybe people think I’m being too loud and obnoxious about my mastectomy, but I just want to encourage people to take their health options into their own hands. I hope no woman is afraid to have a mastectomy because she feels it will make her unattractive, or is worried that a guy won’t be turned by a girl who has mastectomy scars or no nipples. (I was lucky to be able to keep mine in the end, but that’s not always the case with mastectomies.)

Now I’m trying to live my life with a little less anxiety about developing breast cancer, but it’s weird being a single 26-year-old without parents or my old boobs. I’m a comedian, so this experience has given me some great material, but I try not to let it define me.

People sometimes tell me I’m brave, which I don’t entirely I agree with. I’m just terrified of getting cancer and losing my hair like my mom did! But I suppose bravery is being scared of something and doing it anyway, and I did do that.

Now, with my new artificial boobs, I don’t need to be as afraid I’ll end up like my mom. I don’t need to get mammograms; I don’t need visit the oncologist every few months. And the best part: I don’t even need to go bra shopping.

Backless dresses, here I come!

Eden Dranger is a writer and stand up comedian living in Los Angeles.

TIME Ideas hosts the world's leading voices, providing commentary and expertise on the most compelling events in news, society, and culture. We welcome outside contributions. To submit a piece, email ideas@time.com.

TIME Opinion

When Is ‘Awareness’ Awareness Month?

Charlotte Alter for TIME

Be aware. Be very aware.

October is Breast Cancer Awareness Month, which means it’s time to briefly contemplate getting a mammogram while munching on a pink cookie. But it’s also Domestic Violence Awareness Month, so you should probably tweet angrily about the NFL. And AIDS Awareness Month, so why not finish watching The Normal Heart?

Don’t forget October is also Rett Syndrome Awareness Month, Selective Mutism Awareness Month, and Vegetarian Awareness Month. And Dental Hygiene Awareness Month, which means you should feel extra guilty for forgetting to floss. With so much heightened awareness, who needs LSD?

All these good intentions seem harmless enough, but beneath the T-shirts and cookies and colored ribbons lurks a silent threat. It’s hard to detect, harder to contain, and extremely contagious. It can lead to compulsive “liking” and hashtag abuse. In the advanced stages, it can cause Facebook profile pictures to spontaneously mutate.

It’s time to sound the alarm: we need an Awareness Awareness Month.

“Awareness” is a virus that preys on well-meaning minds. It tricks us into thinking that thought is the same as action, that acknowledging something is the same as fixing it. Awareness is a problem masquerading as a solution.

Of course, awareness is a necessary first step in getting anything done. We can’t cure breast cancer, or end domestic violence, or fight AIDS unless we’re paying attention to them. But awareness should be the first step towards action, not the last. It’s the means to an end, not the end in itself.

And that’s exactly the problem– Now that “awareness” is so trendy, we seem to have forgotten about that pesky second part, the part where we actually do something. How convenient to think that awareness is enough! How satisfying for us to think that a momentary synapse twitch in our brains counts as a meaningful step towards change. It’s part of a crisis of tangibility, where we confuse mental thoughts, or digital clicks, for real action. “Awareness” is a direct descendent of the “if you can dream it, you can do it!” mentality on which Millennials were weaned. Only we’ve got it mixed up now– we think dreaming it is doing it.

Newsflash: only Roald Dahl’s Matilda can move things with her mind.

Take, for example, the HeforShe campaign that the United Nations launched in September with a “groundbreaking” speech by Emma Watson. The goal of the campaign was to get 1 billion men to sign the HeforShe pledge, in a “solidarity movement” to stand up for gender equality. Watson’s speech was a beautiful, articulate defense of feminism that went appropriately viral. But it promised no concrete action towards educating women or stopping gender-based violence–no funding, no organized policy strategy, no legislation. More than 171,000 men have so far signed the HeforShe petition, but what does that even mean? They’ve just pressed a button saying they support women–that’s like pressing a button saying “I’m not a racist.” It’s easier than checking “agree” on the iTunes Terms & Conditions.

Meanwhile, an entire page of the program accompanying the UN event was dedicated to explaining why UNWomen had chosen a particular color of magenta to represent HeforShe: “Viscerally alive, iconic and fresh, daring and courageous, HeforShe Magenta walks the fine line between male and female, making it the ideal shade to speak to the elimination of gender inequality.”

The magenta sounds lovely, but somehow I doubt Boko Haram has been waiting to release the girls until the UN developed the perfect shade of pink.

Or look at the new testicular-cancer-awareness #FeelingNuts campaign, which was recently endorsed by Hugh Jackman when he tweeted a picture of himself holding his own (clothed) balls. The scrotum-squeeze has gone viral, but how much money has been raised to fight testicular cancer? It’s hard to tell, because the campaign doesn’t require any kind of donation, unlike the ALS Ice Bucket Challenge. And there’s no evidence that the thousands who take pictures of themselves holding their balls are doing any kind of actual screening– they could easily be using the campaign as an excuse for a crotch-grab selfie.

“Awareness” has quickly become another way to be holier-than-thou. Didn’t change your Facebook picture to support marriage equality? You must not care about the obstacles gay people face. Not going topless naked in Times Square? You must not care about the censorship of women’s bodies. Have you seen how many causes I support? Were you aware that I am hyper-aware?

Of course, some awareness campaigns actually do a lot of good, like the aforementioned ALS Ice Bucket Challenge, which raised more than $100 million to fight the debilitating disease. But for every brand that that actually donates to a cause like breast cancer research, there are dozens who “pinkwash” their products, labeling them with pink ribbons while donating only a tiny portion of proceeds or continuing to use carcinogenic chemicals. “Awareness” has become more of a branding opportunity than a public service.

Besides, issues that are well-publicized enough to have Awareness Months are usually already being addressed, somewhat efficiently, by well-funded Western organizations. When is Ebola Awareness Month? What about Child Bride Awareness Month? How about Female Circumcision Awareness Month? Might I suggest January?

See, it’s only a certain kind of cause that gets a whole month of “awareness.” Causes that are big enough to be taken seriously but not too disturbing to display on a yogurt container. Unfortunately, that means lots of big problems– problems that are too terrifying to fit onto a T-shirt — get ignored. And when we congratulate ourselves about how “aware” we are, and jump mindlessly from one cause to the next, we lose sight of the bigger issues that need fixing.

So let’s raise awareness about the danger of empty “awareness.” Let’s spread the word about only spreading the word. I propose we make October Awareness Awareness Month– and YOU can take a stand, by tweeting with the hashtag #awarenessawareness, “liking” my Facebook page, or staring mindlessly at your own hand.

TIME Opinion

How Celebrities Helped Me Get Through Breast Cancer

When I was diagnosed at 40, Betty Ford, Betsey Johnson and Sheryl Crow stepped in

If you’re diagnosed with cancer and you live, you’re graced with a label that’s meant as an honor: “Survivor.” And yes, surviving cancer is a powerful experience that can enrich and embolden the rest of one’s days. But what of people whose lives are taken by the disease? Anyone who has lost a loved one to cancer knows well that people who die of cancer commonly display extraordinary determination, clarity, and grace. We don’t have a fitting term for those people — “victims” is not exactly empowering — and yet, as Breast Cancer Awareness month begins, their experience is just as worthy of being honored.

I took a crash course in these issues when I was diagnosed with breast cancer, at age 40, in 2008. Part of what I learned during that time came from close connections, especially those I found in a national group called the Young Survival Coalition, which provides support and information for younger women facing this diagnosis. At the same time, I also found a community somewhere less expected: with celebrities.

Before connecting with others dealing with the disease, I could immediately turn to the famous women whose experiences I had watched throughout the decades before. I thought of Betsey Johnson, who’d been diagnosed in 2002. She had apparently come through more fabulous than ever; I’d interviewed her a few years before and found her insightful, buoyant, and laughter-filled. I thought of Minnie Riperton, a musician I’d loved all my life. Her candor about her diagnosis earned her a spokesperson position for the American Cancer Society in 1977 and the ACS’s Courage Award, presented by President Jimmy Carter, in 1978. She ultimately died of breast cancer, at 31, but I remembered the impression she’d made on me when I was a child by communicating in public about her illness with honesty and grace.

The list goes on: Sheryl Crow and Christina Applegate emerged from their breast cancer treatments determined to help others who face the disease. Edie Falco was diagnosed at 40, in 2003; she later said that the way long-held wishes came to the fore in her life after cancer treatment encouraged her to adopt her children. Robin Roberts came out about her sexuality after she was treated for a blood disorder that appears likely to have resulted from the chemotherapy she received for breast cancer five years before. I also thought of photographer Linda McCartney, diagnosed with breast cancer in 1995. In March of 1998, her face somewhat gaunt and her hair just growing back from chemotherapy, she nonetheless shone with pride at her designer daughter Stella’s fashion show. One month later, she died of the disease — but I will never forget the photos I saw of her that day and how she put herself, though very ill, in the public eye for an event she held dear, living on her terms till the end.

The impact these women can have on those fighting the disease out of the spotlight just goes to show how important it is that celebrities now feel free to speak out if they want to.

That’s where Shirley Temple Black comes in. When the former child star was diagnosed with breast cancer in 1972, it was not only common for women to keep the diagnosis a secret from others, but also for their doctors to keep secrets from them: Doctors often told women they were having a biopsy when in fact a mastectomy was planned; the thinking was that a woman would not be able to handle the news in advance. Black, one of the first women in this country to speak publicly about her breast cancer diagnosis, expressed outrage at this practice: “The doctor can make the incision; I’ll make the decision,” she wrote in McCall’s magazine.

Just two years later, First Lady Betty Ford was diagnosed, mere weeks after her husband took the oath of office. TIME reported that she received what was then the standard surgery for breast cancer: a “radical mastectomy” that “removed the entire right breast, its underlying pectoral muscle, and lymphoid tissue in the adjacent armpit.” Today, less invasive surgical options are far more common, even when a mastectomy is performed. (Ford went on to commit herself to many causes, most famously helping to erase stigma from another illness she faced: addiction.) Within weeks, Happy Rockefeller, the Vice President-designate’s wife, had decided to learn from Ford’s example and perform a breast self-exam. She found a lump in her breast and was diagnosed with breast cancer; Ford was publicly credited with leading Rockefeller toward the diagnosis and what proved to be successful treatment.

The First Lady’s decision to be open about what was still a taboo topic — a frightening illness in a private part of the body — had paid off immediately. And I can attest that the trend she helped start, of sharing a breast cancer experience publicly, continues to make a difference.

These days, of course, one needn’t even be a global celebrity to have a broad impact. In mid-2010, I discovered the writings of journalist Mary Herczog, who had also been treated for breast cancer. I loved her warm, witty writing style; and I loved that she had decided to pursue a doctorate after her initial cancer treatments. I wanted to meet this remarkable survivor — but was devastated to learn that Herczog had died of breast cancer a few months before, at age 45. In a blog entry about a month before her death, Herczog acknowledged her somewhat unusual refusal to despair over terrible medical news. “Either there’s a whole lot of unavoidable bad coming at me,” she said, “in which case I don’t see the need to rush up and greet it, or I feel pretty swell, and I roll out with cookies and good books.” Words to live by, from one whose legacy will continue to survive.

As for what to call those who, like Herczog, were not themselves survivors, one of my friends from the Young Survival Coalition has a suggestion: call them by their names. That goes for boldface names as well as the names of beloved friends.

Meanwhile, whatever term you want to use for someone who had cancer and now shows no evidence of the disease, that’s what I am. And I carry in my heart others who touched my life while they faced the disease — those who survived and those who didn’t — even if I only ever knew them from a distance.

Read TIME’s 2013 cover story about the impact of Angelina Jolie’s mastectomy, free of charge, here in TIME’s archives: The Angelina Effect

TIME Cancer

Waist Size Linked to Breast Cancer, Study Finds

Trading in smaller skirt sizes for bigger ones is linked to a higher risk of breast cancer, finds a new study published in BMJ Open.

But it’s what underneath the skirt—an expanding waist—that counts.

Research already suggests that gaining weight puts women more at risk for breast cancer, since fat tissue spurs the production of estrogen, which feeds the growth of breast tumors. The kind of fat around your waist seems to be especially telling: Some studies have found that waist circumference is better than BMI at assessing the risk for many conditions. In an attempt to give women an “easy to understand message,” researchers of this new study measured waist thickness by the number on their subjects’ skirt tags.

The study looked at data from about 93,000 mostly overweight, postmenopausal women in the U.K. Collaborative Trial of Ovarian Cancer. After gathering various kinds of health data from the women—like general health, cancer status, and, yes, skirt size—for about three years, they analyzed the results.

An increase in skirt size was the single most predictive measure of breast cancer risk, the study concluded. When women went up a single skirt size over a 10-year span between their mid 20s and mid 60s, they were shown to have a 33% greater risk of developing breast cancer after menopause. Buying two skirt sizes up during that same period was linked to a 77% increased risk.

The size of your skirt might seem like a silly stand-in for measuring belly fat, but skirt size “has been shown to provide a reliable and feasible estimate of waist circumference at the population level,” the study reads.

Don’t get too married to the results, though. The study acknowledges that skirt sizing probably varied over the years, as any woman who’s ever shopped at more than one store can tell you. Forget changing skirt size in a decade—you can change skirt size in a minute if you just try a different store, so it should take more than a sudden switch from a 4 to a 6 to freak you out.

TIME Health Care

The Global Problem With Overdiagnosis and Overtreatment

Equipment in a doctors office
Getty Images

Two new studies make a case against too much medicine

It’s a public health conundrum: Current screening guidelines lead to an overdiagnosis of diseases like cancer, which results in overtreatment for ailments that might never seriously impact a person’s health.

We’ve heard the overdiagnosis argument in the U.S. before, especially surrounding breast cancer; in 2009, the United States Preventive Services Task Force recommended against annual breast cancer screening starting at age 40 and instead advised women get mammograms starting at age 50.

Now, two new studies published Monday in the medical journal The BMJ highlight the global problem with overtreatment in both breast cancer and heart disease.

In a new analysis report, a team of researchers conclude that hypertension is being overtreated in people with mild cases of the disease. The researchers write that about 40% of adults worldwide have hypertension, and more than half of those people have mild cases of the disease (meaning they’re low risk and don’t have existing cardiovascular disease). But more than half of people with mild hypertension are being treated with blood pressure-lowering drugs–even though the research on whether this reduces cardiovascular-related disease and death is not established. The researchers argue that the practice is unnecessary and costs $32 billion each year in the U.S. alone.

Instead of recommending lifestyle modifications proven to work, like cutting back on alcohol and exercising more, many doctors opt for drugs because they want to do something right away without having to rely on the often-unhealthy environment beyond their office walls, says study author Vikas Saini, president of the Lown Institute. “[Doctors] need the confidence that we have systems in place that encourage a healthy lifestyle,” he says.

“Most doctors feel a little under siege; they see blood pressure rising and weight going up and they want to do something, but they know they have huge headwinds,” says Saini. “Prescribing a pill is the path of least resistance, but it’s a lot of money.” According to the researchers, the clinical treatment for mild hypertension needs to shift away from a heavy emphasis on drugs.

The second study adds to a growing body of research that supports later initiation into breast cancer screenings. The study authors argue that screening older women over age 70 for breast cancer doesn’t offer enough benefit to be worth it.

In 1998, the upper age limit for breast cancer screening in the Netherlands was extended from age 69 to age 75. The researchers wanted to see if the change actually resulted in fewer late-stage cancers among 70 to 75 year olds, so they looked at about 25,500 new breast cancer patients in a Dutch cancer registry between 1995 to 2011. What they found was that early-stage breast cancer in women 70 to 75 rose sharply after the screening recommendations changed, and while the number of new cases of advanced-stage breast cancer fell significantly, the absolute decrease of those cases was small. For every advanced-stage cancer detected by screening among women over age 70, about 20 “extra” cases were also diagnosed, the researchers concluded.

“Those numbers need to be told to women,” says study author Gerrit Jan Liefers, a surgical oncologist at Leiden University Medical Centre. “We are not voting against screening, but you should individualize your screening to women. To use it as a population-wide tool is wrong. You end up screening women who would never be affected by the cancer.”

The message both studies send to doctors is that physicians need to consider each patient individually and inform men and women of their options.

The two studies are part of the 2014 Preventing Overdiagnosis Conference in Oxford. The BMJ has also launched a “Too Much Medicine” campaign you can follow here.

TIME Cancer

No, Wearing a Bra Will Not Give You Breast Cancer, Study Shows

Ladies, that swath of fabric snapped around your rib cage is not a death trap. A new study published in Cancer Epidemiology, Biomarkers & Prevention found that among 1,500 women, there was no association between bra wearing and breast-cancer risk.

The study authors asked women with and without breast cancer nearly every conceivable question about their lingerie — cup size, how many hours they wore their bras per day, how many of their bras contained underwire, how old they were when they started wearing a bra — and found that none of the factors were associated with cancer.

Why would anyone think the intimates might be connected to tumors in the first place? For that we can thank the very first study on the subject done in 1991 (which makes this just the second). That analysis found that women who didn’t wear bras had a lower risk of breast cancer. The authors were quick to attribute that to more obvious, well-established risk factors like obesity. Thinner women with smaller breasts, after all, are those most likely to go braless.

But somehow the myth spread. On its website, the American Cancer Society (ACS) traces it back to an obscure book called Dressed to Kill. ACS wholly dismisses the book, stating that there are no scientifically valid studies demonstrating that wearing a bra causes any kind of breast cancer. And in the new paper, study author Lu Chen dismisses the false notion that bras impede lymph circulation and drainage, trapping toxins in your breasts that can trigger tumors.

Still, Chen says, undergarments may be an easy target because some people grapple with explaining why breast-cancer rates are higher in the U.S. than in developing countries. “They think one reason breast cancer is more common in developed countries is due to the differences in bra-wearing patterns,” she says — even though far more likely risk factors, like a lack of physical activity and being overweight, not to mention exposure to carcinogens, are more likely to blame.

The rumors clearly aren’t bothering the vast majority of bra wearers. Of the 1,500 women Chen studied, more than 75% wore a bra for at least eight hours per day. And only one woman — who had to be excluded from the analysis because she had no peers — had never worn a bra.

TIME Cancer

Double Mastectomies Are on the Rise, but They Don’t Result in Fewer Deaths

More women have opted for double mastectomies than in the past but new research questions their effectiveness

New research shows that double mastectomies are increasingly used to treat cancer in a single breast, and it doesn’t always result in fewer deaths.

In a new paper published in the journal JAMA, a team of researchers looked at data from a cancer registry in California and found that double mastectomies for early-stage breast cancer increased significantly from 1998 to 2011. When the researchers compared the mortality rates of 189,734 patients who underwent either double/bilateral mastectomies, unilateral mastectomies or breast conserving surgery plus radiation, they found that double mastectomies were not associated with a lower risk of death compared to surgery plus radiation. Unilateral mastectomy had the highest mortality rate.

The researchers also found that double mastectomies increased the most among women who were under age 40 when they were diagnosed. Though the researchers can’t confirm, they suspect that the numbers may be due to the women’s relatively high likelihood of carrying genetic mutations like BRCA1 and BRCA2, as well as the greater likelihood that they have younger children and therefore want to extend their lives for as long as possible. The researchers call this “an emotional rather than evidence-based decision.”

“The increase in bilateral mastectomy use despite the absence of supporting evidence has puzzled clinicians and health policy makers,” the study authors write. “Although fear of cancer recurrence may prompt the decision for bilateral mastectomy, such fear usually exceeds the estimated risk.”

Given the rising numbers and growing concern about over-treatment, the researchers say physicians should really stop and consider how to respond to a patient’s request for double mastectomy, given that it’s an incredibly invasive procedure.

TIME Cancer

Angelina Jolie’s Surgery May Have Doubled Genetic Testing Rates at One Clinic

Actress Angelina Jolie leaves Lancaster House after attending the G8 Foreign Minsters' conference on April 11, 2013 in London.
Actress Angelina Jolie leaves Lancaster House after attending the G8 Foreign Minsters' conference on April 11, 2013 in London. Oli Scarff—Getty Images

When Jolie announced her surgery to prevent cancer due to a genetic predisposition, she encouraged other women to get checked too, study says

In 2013, actress Angelina Jolie announced that she had undergone a preventive double mastectomy because she was a BRCA1 gene mutation carrier, which puts her at very high risk for breast and ovarian cancer. Jolie also had a family history of these cancers.

Soon after, TIME wrote a cover story–“The Angelina Effect“–looking at what impact her decision could have on women who carry the dangerous BRCA1 and BRCA2 genes and therefore may be at risk for breast and ovarian cancers. Now, a new study being presented at the 2014 Breast Cancer Symposium shows that the Angelina effect is indeed real.

The study authors did a retrospective review of records from a cancer center in Canada and discovered that in the six months following Jolie’s highly publicized surgeries, testing and counseling around genetic testing nearly doubled. The researchers compared the number of counseling sessions and testings in the six months before and after the announcement and found that the number of women referred to genetic counselors by physicians increased 90%, and the number of women who qualified for genetic testing increased 105%. The researchers say this led to a two-fold increase in identified BRCA1 and BRCA2 mutation carriers.

“After Angelina Jolie’s story was released, physicians were probably more proactive and referred more patients; at the same time, patients were more likely to request and seek genetic counseling,” said study author Dr. Jacques Raphael, a clinical fellow at Sunnybrook Odette Cancer Centre in Toronto, Canada, in a statement.

Estimates vary, but BRCA1 and BRCA2 gene mutations are said to increase a woman’s risk for breast cancer by well over 50%. Only about two to four of every 1,000 women carry the gene mutation (men can have it too) and it is more common among women with histories of ovarian and breast cancer in their families, as well as people of Ashkenazi Jewish descent.

Jolie isn’t the only celebrity with a known health “effect.” In 2000, TV personality Katie Couric underwent a colonoscopy on live television, which prompted a surge of 20% more colonoscopies across the U.S. (dubbed “The Katie Couric Effect.”) This recent study, although small, suggests that Jolie’s announcement and the resulting media coverage encouraged more women to opt into genetic testing–and that prominent figures like Jolie can impact how women approach their health in real, measurable ways.

TIME Cancer

How Aspirin Can Prevent Breast Cancer

Among overweight and obese women, the painkiller could help to prevent tumors from recurring

Doctors are beginning to learn that body weight could have a role in determining a woman’s risk for breast cancer as well as her ability to survive it — and according to new research, a surprisingly simple over-the-counter drug could help with prevention.

“Obesity by itself is the worst prognostic factor,” says Linda deGraffenried, an associate professor of nutritional sciences at the University of Texas at Austin. “Obese women do worse on hormone therapy, chemotherapy and radiation therapy. We used to think that the mechanism involved the fact that they had [other] conditions such as diabetes or heart disease, but now we are starting to appreciate that the obese patient has a different biological disease.”

And that understanding led deGraffenried and her colleagues to the surprising finding that among women with a higher body mass index (BMI), nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin can actually lower their risk of breast cancer.

In a report published Friday in the journal Cancer Research, deGraffenried found that obese and overweight breast cancer patients who used NSAIDs regularly lowered their risk of getting additional tumors by 52% compared with women who didn’t take the pills. “I’ve been doing cancer research for 20 years, and there has been nothing that was able to give that kind of benefit,” says deGraffenried. “So yes, I was extremely surprised that by just reducing inflammation you could get that significant a benefit.”

What’s happening in obese patients, she says, is that their larger volume of fat tissue promotes production of aromatase, an enzyme involved in producing a form of estrogen called estradiol. Because estrogen is part of the fuel that drives breast-cancer growth, having elevated levels of aromatase is associated with higher rates of breast cancer. The mechanism also explains why drugs that inhibit the enzyme aren’t as effective in obese or overweight women. The fat tissue also promotes release of other factors that are important for tumor survival, creating a feedback loop that keeps the cancer growing in heavier women.

But NSAIDs, which block another enzyme that stimulates aromatase production, could counter this effect. And that’s what deGraffenried and her colleagues found. Among a group of 440 women diagnosed with breast-cancer tumors containing estrogen receptors, those with a BMI greater than 30 and who used NSAIDs regularly had a much lower rate of breast cancer.

Whether women with other types of breast cancer, including tumors without estrogen receptors, can benefit from NSAIDs isn’t clear, but the team is studying those populations as well.

As for whether an aspirin a day should become part of women’s breast-cancer prevention efforts, deGraffenried notes that many already take low-dose aspirin — the same does that most of the women in the study took — to protect against heart disease and colon cancer. “If you are not already on an NSAID or if there is no contraindication for an NSAID, there is reason to consider asking your doctor about it,” she says.

MORE: Osteoporosis Drugs Do Not Prevent Breast Cancer After All

MORE: Breast-Cancer Drug Has a Surprising New Application, Study Finds

TIME Breast Cancer

Osteoporosis Drugs Do Not Prevent Breast Cancer After All

Some studies had hinted that the bone-building treatments may also have an added benefit in fighting tumors, but the latest study doesn’t support that connection

In recent years, several large studies involving tens of thousands of women found a potentially useful connection between bisphosphonates, the popular bone drugs, and a lower risk of breast cancer. But new research published Monday in JAMA Internal Medicine challenges that long-held belief.

In previous observational studies, women who reported taking medications like alendronate (Fosamax) or zoledronic acid (Reclast) to treat osteoporosis also seemed to have lower rates of breast cancer compared to women who didn’t take the medications. There was biological evidence to support the association as well – bisphosphonates were also correlated with lower rates of cell death and hampered cancer cell activity.

But Trisha Hue, an epidemiologist at the University of California, San Francisco, and her colleagues, wondered if the connection could truly be attributed to the osteoporosis medications, or whether there was something else about the women taking these drugs that could explain the cancer trend.

MORE: Combining Bone-Building Drugs Key to Making Bones Stronger

Indeed, when they focused their attention on two studies that randomly assigned women to either a bisphosphonate or placebo, and followed them for up to four years, they found no difference between the women taking the drug and those who did not when it came to their breast cancer rates.

So why the strong connection in previous studies? Hue points out that those analyses, which were not randomized controlled trials, but rather observational studies, could not account for the fact that the drug-taking group may have been biased in some way. And in fact that’s likely what occurred – women who are prescribed bisphosphonates have low bone mineral density, and they also have low levels of the hormone estrogen, which is known to fuel tumor growth. So the earlier studies were not finding a correlation between bisphosphonate use and a lower risk of breast cancer, but instead were picking up the fact that bisphosphonate users were likely to have lower rates of breast cancer to begin with.

MORE: How Often Do Women Really Need Bone Density Tests?

It’s not the first time the benefits of the bone drugs have been called into question. In 2011, some studies found that the therapies could increase the risk of rare bone fractures in the strong bones such as the thigh.

While some doctors and patients may have turned to the bone-building drugs to potentially avoid getting cancer, Hue says “our take-home message is that if you are already on bisphosphonates for prevention of fractures, it’s very effective for preventing fractures. But they shouldn’t be taken specifically for the primary prevention of breast cancer.”

Your browser, Internet Explorer 8 or below, is out of date. It has known security flaws and may not display all features of this and other websites.

Learn how to update your browser